← FDA Drug Approvals (Drugs@FDA)

CYCLOPHOSPHAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XGEN PHARMS · Approved 2022-10-18

Drug application

FDA Application #

ANDA211757

Application type

Abbreviated New Drug Application (Generic)

Brand name

CYCLOPHOSPHAMIDE

Generic name

CYCLOPHOSPHAMIDE

Active ingredients

CYCLOPHOSPHAMIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

XGEN PHARMS

Manufacturer

XGen Pharmaceuticals DJB, Inc.

First approval

2022-10-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown